NEW YORK (GenomeWeb News) – The stocks of most of the 38 firms that comprise the GenomeWeb Daily News Index fell during the month of February, mirroring a drop for the tech-heavy Nasdaq market.

Overall, only nine of the companies in the Index closed the month up compared to January's close. Orchid Cellmark gained around 30 percent to close at $.70, while other notable gainers included CombiMatrix (+15 percent), Illumina (+15 percent), and Life Technologies (+14 percent).

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: issues in reproducibility, circulating DNA predicts breast cancer relapse, and more.

Because of an autoimmune disorder, a man has been shedding live polioviruses for 28 years, according to an analysis appearing in PLOS Pathogens.

Being in a long-term collaboration can increase researchers' citation rates by 17 percent, a recent analysis says.

By analyzing tweets, Canadian researchers examine the public's view of gene patenting.